Literature DB >> 26305941

IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.

Rebecca A Sosa1, Cathi Murphey1, Rachel R Robinson1, Thomas G Forsthuber2.   

Abstract

Evidence has suggested both a pathogenic and a protective role for the proinflammatory cytokine IFN-γ in experimental autoimmune encephalomyelitis (EAE). However, the mechanisms underlying the protective role of IFN-γ in EAE have not been fully resolved, particularly in the context of CNS antigen-presenting cells (APCs). In this study we examined the role of IFN-γ in myelin antigen uptake by CNS APCs during EAE. We found that myelin antigen colocalization with APCs was decreased substantially and that EAE was significantly more severe and showed a chronic-progressive course in IFN-γ knockout (IFN-γ-/-) or IFN-γ receptor knockout (IFN-γR-/-) mice as compared with WT animals. IFN-γ was a critical regulator of phagocytic/activating receptors on CNS APCs. Importantly, "free" myelin debris and lipid peroxidation activity at CNS lesions was increased in mice lacking IFN-γ signaling. Treatment with N-acetyl-l-cysteine, a potent antioxidant, abolished lipid peroxidation activity and ameliorated EAE in IFN-γ-signaling-deficient mice. Taken together the data suggest a protective role for IFN-γ in EAE by regulating the removal of myelin debris by CNS APCs and thereby limiting the substrate available for the generation of neurotoxic lipid peroxidation products.

Entities:  

Keywords:  APC; EAE; T cell; interferon-gamma; myelin debris

Mesh:

Substances:

Year:  2015        PMID: 26305941      PMCID: PMC4568689          DOI: 10.1073/pnas.1505955112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  67 in total

1.  Identification of a microglia phenotype supportive of remyelination.

Authors:  Marta Olah; Sandra Amor; Nieske Brouwer; Jonathan Vinet; Bart Eggen; Knut Biber; Hendrikus W G M Boddeke
Journal:  Glia       Date:  2011-11-09       Impact factor: 7.452

2.  Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

Authors:  Melanie Greter; Frank L Heppner; Maria P Lemos; Bernhard M Odermatt; Norbert Goebels; Terri Laufer; Randolph J Noelle; Burkhard Becher
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

3.  Macrophage tolerance: CD47-SIRP-alpha-mediated signals matter.

Authors:  Hitoshi Takizawa; Markus G Manz
Journal:  Nat Immunol       Date:  2007-12       Impact factor: 25.606

4.  Deletion of the murine scavenger receptor CD68.

Authors:  Li Song; Carolyn Lee; Christian Schindler
Journal:  J Lipid Res       Date:  2011-05-13       Impact factor: 5.922

5.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.

Authors:  Eugene D Ponomarev; Leah P Shriver; Katarzyna Maresz; Bonnie N Dittel
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

Review 6.  Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.

Authors:  Takashi Matozaki; Yoji Murata; Hideki Okazawa; Hiroshi Ohnishi
Journal:  Trends Cell Biol       Date:  2009-01-12       Impact factor: 20.808

7.  [Lipid peroxidation and antioxidant defence enzyme activity in multiple sclerosis].

Authors:  E P Pasichna; R P Morozova; H V Donchenko; S M Vinychuk; O O Kopchak
Journal:  Ukr Biokhim Zh (1999)       Date:  2007 Sep-Oct

8.  Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Dusica Pavlovic; Maja Milojkovic; Dusan Sokolovic; Ivana Stevanovic; Aleksandar Petrovic
Journal:  Folia Neuropathol       Date:  2013       Impact factor: 2.038

9.  The effect of the shiverer mutation on myelin basic protein expression in homozygous and heterozygous mouse brain.

Authors:  E Barbarese; M L Nielson; J H Carson
Journal:  J Neurochem       Date:  1983-06       Impact factor: 5.372

10.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

View more
  20 in total

Review 1.  Cytokine networks in neuroinflammation.

Authors:  Burkhard Becher; Sabine Spath; Joan Goverman
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

Review 2.  The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.

Authors:  Rachel R Robinson; Alina K Dietz; Asif M Maroof; Reto Asmis; Thomas G Forsthuber
Journal:  Immunotherapy       Date:  2019-02       Impact factor: 4.196

Review 3.  Myeloid cells - targets of medication in multiple sclerosis.

Authors:  Manoj K Mishra; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

4.  Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.

Authors:  Sahar Salehi; Rebecca A Sosa; Yi-Ping Jin; Shoichi Kageyama; Michael C Fishbein; Enrique Rozengurt; Jerzy W Kupiec-Weglinski; Elaine F Reed
Journal:  Am J Transplant       Date:  2017-11-23       Impact factor: 8.086

5.  Edaravone Inhibits the Production of Reactive Oxygen Species in Phagocytosis- and PKC-Stimulated Granulocytes from Multiple Sclerosis Patients Edaravone Modulate Oxidative Stress in Multiple Sclerosis.

Authors:  Pedro Henrique Villar-Delfino; Nathália Augusta Oliveira Gomes; Paulo Pereira Christo; José Augusto Nogueira-Machado; Caroline Maria Oliveira Volpe
Journal:  J Cent Nerv Syst Dis       Date:  2022-05-16

6.  Neuroinflammation creates an immune regulatory niche at the meningeal lymphatic vasculature near the cribriform plate.

Authors:  Martin Hsu; Collin Laaker; Andy Madrid; Melinda Herbath; Yun Hwa Choi; Matyas Sandor; Zsuzsanna Fabry
Journal:  Nat Immunol       Date:  2022-03-28       Impact factor: 31.250

7.  The control of oligodendrocyte bioenergetics by interferon-gamma (IFN-γ) and Src homology region 2 domain-containing phosphatase-1 (SHP-1).

Authors:  Scott B Minchenberg; Paul T Massa
Journal:  J Neuroimmunol       Date:  2017-10-28       Impact factor: 3.478

8.  Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis.

Authors:  Itay Raphael; Johanna Webb; Francisco Gomez-Rivera; Carol A Chase Huizar; Rishein Gupta; Bernard P Arulanandam; Yufeng Wang; William E Haskins; Thomas G Forsthuber
Journal:  Front Immunol       Date:  2017-07-17       Impact factor: 7.561

9.  Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.

Authors:  Rebecca A Sosa; Allyson Q Terry; Fady M Kaldas; Yi-Ping Jin; Maura Rossetti; Takahiro Ito; Fang Li; Richard S Ahn; Bita V Naini; Victoria M Groysberg; Ying Zheng; Antony Aziz; Jessica Nevarez-Mejia; Ali Zarrinpar; Ronald W Busuttil; David W Gjertson; Jerzy W Kupiec-Weglinski; Elaine F Reed
Journal:  Hepatology       Date:  2020-10-30       Impact factor: 17.425

Review 10.  Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.

Authors:  Flávia Castro; Ana Patrícia Cardoso; Raquel Madeira Gonçalves; Karine Serre; Maria José Oliveira
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.